This trial is comparing two different blood clot treatments to see which one results in better outcomes for patients who have had a stroke.
1 Primary · 7 Secondary · Reporting Duration: 2 at 24 hours after randomization
Experimental Treatment
Non-Treatment Group
1200 Total Participants · 3 Treatment Groups
Primary Treatment: Argatroban · Has Placebo Group · Phase 3
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:New York | 100.0% |
Did not meet criteria | 100.0% |